Pentamidine Isethionate Injection
Brand names: Pentamidine Isethionate
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Mar 23, 2026 · First posted: Mar 23, 2026 · 1 manufacturers, 1 listed presentations
As of Mar 23, 2026, the FDA lists Pentamidine Isethionate Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) NDC 39822-3050-2 |
XGen Pharmaceuticals DJB, Inc. | Not specified | A business decision was made to discontinue manufacture of the drug. |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Pentamidine Isethionate Injection (FDA data as of Mar 23, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Pentamidine Isethionate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/pentamidine-isethionate-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).